Free Online Video Targets Heart Health for People with Type 2 Diabetes
Diabetes educator, Gary Scheiner gives his in-depth review of the newly approved Abbott Freestyle Libre CGM continuous glucose monitor. Faster than the fastest meter. More powerful than point-in-time measurements. Able to leap piles of test strips with a single scan. Look… on pharmacy shelves (soon). It’s a meter. It’s a CGM. It’s FREESTYLE LIBRE! Seriously, this is exciting. Abbott’s Frestyle Libre has finally been approved for sale in the United States. Why the excitement? Because it almost eliminates the need for fingerstick blood glucose measurements. It has features of a CGM (continuous glucose monitor) and a blood glucose meter combined in one device. And it is simple to use, reasonably accurate, virtually painless, and relatively inexpensive ($60 for the durable receiver/scanner, $40 per sensor; insurance coverage pending). Super! How does it work? An applicator device is placed on the back of the arm. With one push, a tiny glucose-sensitive filament is inserted just below the skin, with the waterproof transmitter (about the size of two stacked quarters) attached and adhered to the skin. After a 12-hour warmup period, a signal is sent every minute to a handheld receiver about the size of a small cell phone, and the current glucose level along with a trend arrow and graph of the most recent eight hours of data is displayed. The sensor/transmitter is replaced every 10 days. And because of its accuracy, NO fingerstick calibrations are required. A very similar device has been available in Europe and other parts of the world since 2014. The hardware is basically the same, but there are a few subtle differences between the US version and the European version. The European sensors last 14 days [...]
The 670G represents an important step towards fully automating glucose control. However, it is important to put it in the proper context and set expectations at an appropriate level.
what happens when we eat with reckless abandon and blood glucose levels start to head in the wrong direction? Being the responsible individuals we are, we usually place the blame squarely where it belongs: on our medication.
Novo Nordisk’s new FiASP insulin (short for Faster insulin Aspart) has hit the market in various parts of the world, and is awaiting FDA clearance here in the US.
By avoiding the need to absorb through the fat layer below the skin, Afrezza starts working almost immediately, peaks in about 15 minutes, and in most cases, clears in about 2 hours. Now that’s rapid!
If you think you’ve mastered everything there is to know about carb counting, it’s time for a little revelation. Not all carbs are created equal. Another factor to consider is the influence of the Glycemic Index.
Nowadays, travel involves more hassles than most of us are equipped to handle. And having diabetes just adds to the fun. Luckily you have me, Mr. “Platinum-Status Flier,” to share a few pointers for making travel a bit more bearable and enjoyable.
Meters should be within 10% of lab values to be considered accurate. The more often a meter falls within 10% (or 10 points) of the lab value, the more reliable it will be.
Companion Medical won FDA 510(k) approval for its wireless-enabled InPen insulin pen and mobile application. InPen is a new injector pen that actually contains computer chip technology built right into the base, including Bluetooth LE wireless capability.
Among the more exciting developments from from AADE was the unveiling of Medtronic’s new 630G insulin pump, which received FDA clearance just a few days ago. I had a chance to “play around” with the new pump, and here’s what I learned...
There are a multitude of different groups working on hybrid closed loop projects, and each one runs on its own unique proportion of automation and brain-power. Here are a few of the projects that were presented and discussed at the ADA Scientific Sessions in New Orleans this past June.